WILSON TROY EDWARD sold $46K of PBYI
WILSON TROY EDWARD sold 5,000 shares of PUMA BIOTECHNOLOGY, INC. (PBYI) at $9.10 on 2026-09-14 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The transaction is small relative to total holdings and likely has limited immediate market impact, but signals a slight negative sentiment.
Market read
Relevant for traders monitoring insider activity in biotech stocks; may influence short‑term trading decisions.
What to watch
Director still holds 54,750 shares, indicating continued confidence; broader market conditions may dominate price movement.
Background
Form 4 filing discloses a director's sale of Puma Biotechnology shares under a pre‑arranged 10b5‑1 plan.
Ticker impact
Director Wilson Troy Edward sold 5,000 shares of Puma Biotechnology for $45,500 on 2026-09-14.
Potential short-term dip of 1‑2% if market reacts to insider sell.
Sale amount is modest relative to total holdings; executed under pre‑arranged plan, reducing informational value.
Market effects
Minimal effect on biotech sector; insider sales are common and not sector‑wide catalyst.
No notable regional impact.
Limited to investors tracking Puma Biotechnology.
Counterpoint
Insider sale may be routine under 10b5‑1; price could remain stable or rise on fundamentals.
Key entities
- CompanyPuma Biotechnology, Inc.
Biotech firm developing oncology therapies.
- IndividualWilson Troy Edward
Director of Puma Biotechnology.
